After Xiidra deal with Bausch, Novartis divests Indian eye care brands to J.B. Pharma for $116M
After Xiidra deal with Bausch, Novartis divests Indian eye care brands to J.B. Pharma for $116M
fkansteiner
Wed, 12/20/2023 - 09:48
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *